Company Filing History:
Years Active: 1988
Title: The Innovative Contributions of J. Donald Wiggins
Introduction: J. Donald Wiggins, based in Princeton Junction, NJ, is an accomplished inventor known for his significant contribution to pharmaceutical excipients. With a focus on the formulation and composition of materials, he has garnered recognition for his innovative work, particularly in the development of coprocessed materials.
Latest Patents: Wiggins holds one patent titled "Coprocessed microcrystalline cellulose and calcium carbonate composition." This invention presents a unique particulate composition with a weight ratio of microcrystalline cellulose to calcium carbonate ranging from about 75:25 to 35:65. The coprocessed composition serves as an effective pharmaceutical excipient, showcasing Wiggins' commitment to enhancing drug formulation efficiency. The method for preparing this composition involves creating a well-dispersed aqueous slurry of both components, followed by drying the slurry—preferably through spray drying—to produce a fine particulate product.
Career Highlights: J. Donald Wiggins is associated with FMC Corporation, a company known for its extensive work in the agricultural sciences, food technologies, and pharmaceutical sectors. His role within the company allows him to leverage his expertise in developing composite materials for various applications, directly impacting the industry.
Collaborations: Throughout his career, Wiggins has collaborated with notable colleagues, including Dev K. Mehra and Kenneth P. West. These partnerships signify the collaborative spirit in research and development, fostering innovation through shared expertise and experience.
Conclusion: J. Donald Wiggins exemplifies the role of an inventor in advancing pharmaceutical formulation. His patent for coprocessed microcrystalline cellulose and calcium carbonate composition highlights the integration of innovative approaches in creating effective excipients. With continued collaboration and dedication, Wiggins contributes to the growth of pharmaceutical sciences and the betterment of drug delivery systems.